What is Evommune 's share buybacks?

Evommune (EVMN) reported share buybacks of $150.6K in Q1 2026.

How has Evommune 's share buybacks changed year-over-year?

Evommune 's share buybacks decreased by 49.6% year-over-year, from $298.86K to $150.6K.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Evommune EVMN Share Buybacks

Share Buybacks at other companies

HES

Hess MidstreamHESM

$60M-40.0%

Cabot CorporationCBT

$49M+4.3%

Travel + LeisureTNL

$87M+24.3%

UnifirstUNF

$32.74M+414%

MYR GroupMYRG

$0-100%

PennyMac Financial Services, Inc.PFSI

$50.01M+4,121%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:StockRepurchasedDuringPeriodValue.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's share buybacks?: Evommune (EVMN) reported share buybacks of $150.6K in Q1 2026.
How has Evommune 's share buybacks changed year-over-year?: Evommune 's share buybacks decreased by 49.6% year-over-year, from $298.86K to $150.6K.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.